Evidence map›Paper›PMID 42446903›Full record

ArticleReproduction & fertility2026

Global trends and insights in cervical cancer research: a bibliometric analysis from 2000 to 2024.

Jianxiang Cheng, Miaoling Li, Chengcheng Li, Jin Ding, Yi Guo, Yang Shen, Xiaoyuan Hao

Abstract read
In one paragraph

Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianxiang ChengDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.
Miaoling LiDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.
Chengcheng LiDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.
Jin DingDepartment of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University , Nanjing, China.
Yi GuoDepartment of Laboratory Medicine, The Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.
Yang ShenDepartment of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University , Nanjing, China.
Xiaoyuan HaoDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China.ORCID 0009-0000-1327-6020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

graphical abstractABSTRACT: Cervical cancer is the fourth most common malignant disease in women worldwide. Although the promotion and use of human papillomavirus (HPV) vaccinations have, to some extent, reduced the incidence of cervical cancer, problems persist, particularly in low- and middle-income nations. This bibliometric study, which shows the worldwide landscape of cervical cancer research from 2000 to 2024 through scientometric analysis of Web of Science Core Collection publications, provides significant insights into key research topics, new trends, and the networks of collaboration within this field. Early studies concentrated on HPV's role in cervical cancer, whereas more recent studies highlight advances in HPV vaccinations, molecular biology, targeted therapies, and artificial intelligence (AI) applications in cervical cancer screening. However, global health disparities, vaccine accessibility, and regional disease burden remain significant challenges. This study provides a comprehensive summary for academics, clinicians, and policymakers to inform future research efforts to reduce the global incidence of cervical cancer. LAY SUMMARY: Cervical cancer remains a significant health threat for women worldwide. While the development and use of the HPV vaccine have been a major step forward in prevention, this progress has not been equal everywhere. Women in low- and middle-income countries continue to be disproportionately affected. We created a detailed 'map' of all global cervical cancer research from 2000 to 2024. By analyzing thousands of scientific publications, we identified the main topics, newest trends, and how researchers around the world are collaborating. Early research focused on establishing the link between the HPV virus and cervical cancer. Today, the focus has shifted to improving HPV vaccines, understanding the disease at a molecular level, developing new targeted drugs, and using AI to improve screening accuracy. The study highlights that major obstacles remain, including unequal access to vaccines, vast global health disparities, and the heavy burden of the disease in specific regions. This comprehensive analysis serves as a valuable guide for scientists, doctors, and health policymakers. It helps direct future efforts and resources toward the most promising research, with the ultimate goal of reducing the global impact of cervical cancer on all women.

Indexed as

BibliometricsBiomedical ResearchUterine Cervical NeoplasmsFemaleGlobal HealthHuman Papillomavirus VirusesHumansPapillomavirus InfectionsPapillomavirus VaccinesPapillomavirus Vaccinescervical cancerglobal healthhuman papillomavirusscientometric analysis

Identifiers

PMID42446903
PMCPMC13427975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.